Such patients may be less responsive to positive inotropic agents, whereas the beneficial effects of nesiritide, which are not dependent on the β-adrenergic receptor signal-transduction pathway ...

AstraZeneca’s supplemental New Drug Application (sNDA) for CALQUENCE ® (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously ...

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease ...

[1] In the end stages of a terminal disease, dyspnea is a distressing and common symptom. Up to 70% of patients with advanced cancer of all types have dyspnea near the end of life. [2] Drug ...

Twelve disciples chosen; questions sent by John the Baptist; great invitation. And as ye go, preach, saying, The Kingdom of Heaven is at hand (Matt. 10:7). The Christian has a “sheep-like” nature, but ...

There’s no one-size-fits-all solution in tech skill development. Teams are made up of beginners, gurus, and everyone between. Our many-paths-fit-all solution supports their progress so they have the ...